Cardiotoxicity of digitalis glycosides: Roles of autonomic pathways, autacoids and ion channels

Autonomic and Autacoid Pharmacology

Volumn 25, Issue 2, 2005, Pages 35-52

  Demiryurek A T ^a   Demiryurek S ^b  

^a GAZIANTEP UNIVERSITY   (Turkey)

^b GAZI UNIVERSITY   (Turkey)

Author keywords

Arrhythmia; Cardiac glycosides; Cardiotoxicity; Cellular mechanisms; Digitalis

Indexed keywords

ACTIVATED CARBON; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ALPHA 2 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; ATROPINE; AUTACOID; AZEPEXOLE; BETA 1 ADRENERGIC RECEPTOR; BETA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM; CALCIUM CHANNEL; CLONIDINE; CORYNANTHINE; DIGITALIS GLYCOSIDE; DIGOXIN; DIGOXIN ANTIBODY F(AB) FRAGMENT; GLYCEROPHOSPHATE MAGNESIUM; IMIDAZOLINE RECEPTOR; ION CHANNEL; KETAMINE; LIDOCAINE; MAGNESIUM; MAGNESIUM SULFATE; PHENTOLAMINE; PHENYLEPHRINE; PHENYTOIN; POTASSIUM CHANNEL; POTASSIUM SALT; PROPRANOLOL; SODIUM; SODIUM CALCIUM EXCHANGE PROTEIN; SODIUM CHANNEL; UNCLASSIFIED DRUG; UNINDEXED DRUG; YOHIMBINE;

ADRENERGIC SYSTEM; CALCIUM CELL LEVEL; CARDIOTOXICITY; CARDIOVERSION; CHOLINERGIC SYSTEM; CLINICAL TRIAL; DIGITALIS INTOXICATION; DRUG EFFICACY; DRUG MECHANISM; HEART ARRHYTHMIA; HEART DISEASE; HEART FAILURE; HEART PACING; HEMODIALYSIS; HUMAN; INOTROPISM; NONHUMAN; PLASMAPHERESIS; POTASSIUM CURRENT; PROTON SODIUM EXCHANGE; REVIEW; SODIUM CALCIUM EXCHANGE; SODIUM CELL LEVEL;

ANIMALS; AUTACOIDS; AUTONOMIC PATHWAYS; CARDIOTONIC AGENTS; DIGITALIS GLYCOSIDES; HEART DISEASES; HUMANS; ION CHANNELS;

EID: 15944397361     PISSN: 14748665     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1474-8673.2004.00334.x     Document Type: Review

References (137)

1. +-ATPase, myocytes and the heart. Life Sci., 48, 97-106.
2. ALKADI, H.O., NOOMAN, M.A. & RAJA'A, Y.A. (2004). Effect of gentamicin on serum digoxin level in patients with congestive heart failure. Pharm. World Sci., 26, 107-109.
3. +-ATPaSe activity in guinea-pig heart preparations: comparison with ouabain. Arch. Int. Pharmacodyn. Ther., 310, 94-101.
4. ALTUG, S., UZUN, O., DEMIRYUREK, A.T., CAKICI, I., ABACIOGLU, N. & KANZIK, I. (1999). The role of nitric oxide in digoxin-induced arrhythmias in guinea-pigs. Pharmacol. Toxicol., 84, 3-8.
5. ANTMAN, E.M., WENGER, T.L., BUTLER, V.P. Jr, HABER, E. & SMITH, T.W. (1990). Treatment of 150 cases of life-threatening digitalis intoxication with digoxin-specific Fab antibody fragments. Final report of a multicenter study. Circulation, 81, 1744-1752.
6. ARK, M., CAKICI, I., SARIAHMETOGLU, M. & KANZIK, I. (1999). Does prevention of free radical reactions influence digoxin-arrhythmias? Gen. Pharmacol., 32, 627-630.
7. BECKMAN, J.S., BECKMAN, T.W., CHEN, J., MARSHALL, P.A. & FREEMAN, B.A. (1990). Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc. Natl Acad. Sci. USA, 87, 1620-1624.
8. BEITZ, J., SCHNEIDER, S., RIEDEL, A. & MEST, H.J. (1987). Do endogenous lipoproteins modulate the sensibility of animals against arrhythmogenic drugs? Prostaglandins Leukot. Med., 28, 215-220.
9. BERNAUER, W. (1982). Relation of enzyme release and ATP content in digoxin-intoxicated guinea-pig hearts. Basic Res. Cardiol., 77, 449-459.
10. BERNAUER, W. (1994). Release of adenine nucleotide metabolites by toxic concentrations of cardiac glycosides. Basic Res. Cardiol., 89, 308-321.
11. BUSH, L.R., EVANS, R.M., GAUL, S.L. & D'ALONZO, A.J. (1987). Comparative effects of verapamil, diltiazem and felodipine during experimental digitalis-induced arrhythmias. Pharmacology, 34, 111-120.
12. CAKICI, I., MATARACI, N., ERSOY, S., TUNCTAN, B., ABACIOGLU, N. & KANZIK, I. (1995). Effects of platelet-activating factor antagonists WEB 2086 and BN 50730 on digoxin-induced arrhythmias. Pharmacol. Toxicol., 76, 343-347.
13. CARGNELLI, G., BOVA, S., CANNAS, S., DEBETTO, P. & LUCIANI, S. (1994). Effect of amiloride on inotropic and toxic actions of ouabain in guinea-pig left atria. Eur. J. Pharmacol., 292, 103-110.
14. 2-adrenoceptors in cats. Br. J. Pharmacol., 103, 1114-1118.
15. CHILLET, P., KORACH, J.M., PETITPAS, D., VINCENT, N., POIRON, L., BARBIER, B., BOAZIS, M. & BERGER, P.H. (2002). Digoxin poisoning and anuric acute renal failure: efficiency of the treatment associating digoxin-specific antibodies (Fab) and plasma exchanges. Int. J. Artif. Organs, 25, 538-541.
16. CLAUSEN, T. (1998). Clinical and therapeutic significance of the Na+,K+ pump. Clin. Sci. (Lond.), 95, 3-17.
17. DEMIRYUREK, A.T., CAKICI, I. & KANZIK, I. (1998). Peroxynitrite: a putative cytotoxin. Pharmacol. Toxicol., 82, 113-117.
18. DEMIRYUREK, A.T., YILDIZ, G., ESIYOK, S. & ALTUG, S. (2002). Protective effects of poly (ADP-ribose) synthase inhibitors on digoxin-induced cardiotoxicity in guinea-pig isolated hearts. Pharmacol. Res., 45, 189-194.
19. DOCHERTY, J.C., KUZIO, B., SILVESTER, J.A., BOWES, J. & THIEMERMANN, C. (1998). An inhibitor of poly (ADP-ribose) synthetase activity reduces contractile dysfunction and preserves high energy phosphate levels during reperfusion of the ischaemic rat heart. Br. J. Pharmacol., 127, 1518-1524.
20. DUTTA, S., MARKS, B.H. & SCHOENER, E.P. (1977). Accumulation of radioactive cardiac glycosides by various brain regions in relation to the dysrhythmogenic effect. Br. J. Pharmacol., 59, 101-106.
21. DZIELSKA-OLCZAK, M., POLAKOWSKI, P. & KUBIK-BOGUCKA, E. (1998). Evaluation of antiarrhythmic activity of captopril and enalaprilat in experimental cardiac arrhythmias in rabbits. Part I. Pol. J. Pharmacol., 50, 225-231.
22. EISNER, D.A. & VALDEOLMILLOS, M. (1987). A study of intracellular calcium oscillations in sheep cardiac Purkinje fibres measured at the single cell level. J. Physiol., 372, 539-556.
23. ERCAN, Z.S., ILHAN, M., KILINC, M. & TURKER, R.K. (1996). Arrhythmogenic action of endothelin peptides in isolated perfused whole hearts from guinea pigs and rats. Pharmacology, 53, 234-240.
24. FILIPPELLI, A., CUPARENCU, B., FALCIANI, M., DE NOVELLIS, V., SAFTA, L., ARUSTEI, V. & ROSSI, F. (1994). Effects of the intracerebroventricular administration of ketamine on centrogenic arrhythmias in anaesthetized rats. Res. Commun. Chem. Pathol. Pharmacol., 84, 331-340.
25. + channel openers. Pharmacol. Ther., 85, 39-53.
26. GILLIS, R.A. (1969). Cardiac sympathetic nerve activity, changes induced by ouabain and propranolol. Science, 166, 508-510.
27. 4 receptor antagonist, L-648,051, and a dual inhibitor lipoxygenase and cyclooxygenase, BW-755C, on digoxin-induced arrhythmias in guinea-pigs. Arch. Int. Pharmacodyn. Ther., 321, 72-80.
28. GOK S., ULKER, S., HUSEYINOV, A. & EVINC, A. (1997). Effects of a lipoxygenase inhibitor on digoxin-induced cardiac arrhythmias in the isolated perfused guinea-pig heart. Gen. Pharmacol., 29, 789-792.
29. GOK, S., ULKER, S. & EVING, A. (1998). Possible contribution of leukotrienes in the arrhythmogenic effects of digoxin on isolated guinea-pig hearts. Pharmacology, 57, 279-284.
30. GOLDBERGER, J.J. & ARONSON, R.S. (1992). Effects of verapamil on ventricular tachycardia induced by ouabain in guinea pigs. Pacing Clin. Electrophysiol., 15, 162-170.
31. GOLOVINA, V.A., ZAKHAROV, S.I., BOGDANOV, K.Y.U. & ROSENSHTRAUKH, L.V. (1988). Analysis of antiarrhythmic effect of ryanodine in guinea-pigs. J. Mol. Cell. Cardiol., 20, 303-311.
32. +-ATPase. J. Biol. Chem., 275, 27832-27837.
33. HAUPTMAN, P.J. & KELLY, R.A. (1999). Digitalis. Circulation, 99, 1265-1270.
34. HIRASAWA, A., AWAJI, T., HOSONO, M., HARUNO, A. & HASHIMOTO, K. (1993). Effects of a new forskolin derivative, NKH477, on canine ventricular arrhythmia models. J. Cardiovasc. Pharmacol., 22, 847-851.
35. HUNT, S. A., BAKER, D.W., CHIN, M.H. et al. (2001). ACC/ AHA guidelines for the evaluation and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. Available at: http://www.acc.org/clinical/ guidelines/failure/ III_assessment.htm. Accessed March 3, 2004.
36. HUSBY, P., FARSTAD, M., BROCK-UTNE, J.G., KOLLER, M.E., SEGADAL, L., LUND, T. & OHM, O.J. (2003). Immediate control of life-threatening digoxin intoxication in a child by use of digoxin-specific antibody fragments (Fab). Paediatr. Anaesth., 13, 541-549.
37. JONKMAN, F.A., BODDEKE, H.W. & VAN ZWIETEN, P.A. (1986). Protective activity of calcium entry blockers against ouabain intoxication in anaesthetized guinea pigs. J. Cardiovasc. Pharmacol., 8, 1009-1013.
38. KAFILUDDI, R., KENNEDY, R.H. & SEIFEN, E. (1986). Effects of ryanodine on inotropic and arrhythmogenic actions of cardiotonic steroids. Eur. J. Pharmacol., 131, 273-278.
39. KAFILUDDI, R., KENNEDY, R.H. & SEIFEN, E. (1988). Effects of theophylline on inotropic and arrhythmogenic actions of cardiotonic steroids in guinea pig cardiac muscle. J. Pharmacol. Exp. Ther., 244, 556-563.
40. KAFILUDDI, R., KENNEDY, R.H. & SEIFEN, E. (1989). Extracellular magnesium and cardiotonic steroid toxicity in isolated myocardial preparations. J. Pharmacol. Exp. Ther., 251, 1120-1127.
41. KALYONCU, N.I. & OZYAVUZ, R. (1988). Ketanserin inhibits digoxin-induced arrhythmias in the anaesthetized guinea-pig. Fund. Clin. Pharmacol., 13, 646-649.
42. KANG, J.X. & LEAF, A. (2000). Prevention of fatal cardiac arrhythmias by polyunsaturated fatty acids. Am. J. Clin. Nutr., 71, 202-207.
43. KANTELIP, J.P., MILLART, H., LEPERRE, A., MOUGIN, F. & DIDIER, J.M. (1996). Effects of gallium chloride on changes in action potentials and contraction in guinea pig ventricular muscle. Anticancer Res., 16, 327-332.
44. KANZIK, I., DEMIRYUREK, A.T., ZENGIL, H., ABACIOGLU, N. & DORTLEMEZ, H. (1938). Effects of thromboxane synthetase inhibitor (UK 38,485) and thromboxane receptor antagonist (ICI 185,282) on digoxin-induced arrhythmias in anaesthetized guinea-pigs. Clin. Exp. Pharmacol. Physiol., 15, 927-935.
45. KANZIK, I., ZENGIL, H., IPEK, N., CAKICI, I., ABACIOGLU, N. & DORTLEMEZ, H. (1991). Synergism between UK 38485 and ICI 185282 against digoxin-induced arrhythmias in guinea-pigs. Arch. Int. Pharmacodyn. Ther., 312, 55-65.
46. KANZIK, I., CAKICI, I., ERSOY, S., ARK, M., ABACIOGLU, N. & ZENGIL, H. (1992). Effects of cyclooxygenase and lipoxygenase inhibitors on digoxin-induced arrhythmias and haemodynamics in guinea-pigs. Pharmacol. Res., 26, 305-316.
47. KASCHUBE, M. & BRASCH, H. (1991). Negative chronotropic but no antiarrhythmic effect of (+)- and (-)-naloxone in rats and guinea pigs. Cardiovasc. Res., 25, 230-234.
48. KELLY, R.A. & SMITH, T.W. (1992). Recognition and management of digitalis toxicity. Am. J. Cardiol., 69, 108G-119G.
49. KENNEDY, R.H., SEIFEN, E., AKERA, T. & BRODY, T.M. (1986). Effects of BAY K-8644 on inotropic and arrhythmogenic actions of digoxin. Eur. J. Pharmacol., 124, 11-12.
50. KERNAN, W.N., CASTELLSAGUE, J., PERLMAN, G.D. & OSTFELD, A. (1987). Incidence of hospitalization for digitalis toxicity among elderly Americans. Am. J. Med., 96, 426-431.
51. ++ channel blockers. J Pharmacol. Exp. Ther., 239, 206-210.
52. KHATTER, J.C., NAVARATNAM, S. & HOESCHEN, R.J. (1988). Protective effect of verapamil upon ouabain-induced cardiac arrhythmias. Pharmacology, 36, 380-389.
53. KHATTER, J.C., AGBANYO, M., NAVARATNAM, S., NERO, B. & HOESCHEN, R.J. (1989). Digitalis cardiotoxicity: cellular calcium overload a possible mechanism. Basic Res. Cardiol., 84, 553-563.
54. KINLAY, S. & BUCKLEY, N.A. (1995). Magnesium sulphate in the treatment of ventricular arrhythmias due to digoxin toxicity. J. Toxicol. Clin. Toxicol., 33, 55-59.
55. KJELDSEN, K., NORGAARD, A. & GHEORGHIADE, M. (2002). Myocardial Na,K-ATPase: the molecular basis for the hemodynamic effect of digoxin therapy in congestive heart failure. Cardiovasc. Res., 55, 710-713.
56. KOMORI, S., ISHII, M. & HASHIMOTO, K. (1985). Antiarrhythmic effects of coronary vasodilators on canine ventricular arrhythmia models. Jpn. J. Pharmacol., 38, 73-82.
57. LEDERER, W.J. & TSIEN, R.W. (1976). Transient inward current underlying arrhythmogenic effects of cardiotonic steroids in Purkinje fibres. J. Physiol., 263, 73-100.
58. LEE, A.Y., UNANG, T.W., WONG, T.M. (1986). Prevention and reversal of ouabain-induced cardiotoxicity by naloxone in the guinea-pig. Clin. Exp. Pharmacol. Physiol., 13, 55-58.
59. LEVITT, B., CAGIN, N.A., SOMBERG, J., BOUNOUS, H., MITTAG, T. & RAINES, A. (1973). Alteration of the effects and distribution of ouabain by spinal cord transection in the cat. J. Pharmacol. Exp. Ther., 185, 24-28.
60. LEWIS, R.V., TREGASKIS, B., MCLAY, J., SERVICE, E. & MCDEVITT, D.G. (1990). Oral magnesium reduces ventricular ectopy in digitalised patients with chronic atrial fibrillation. Eur. J. Clin. Pharmacol., 38, 107-110.
61. LI, Y., KANG, J.X. & LEAF, A. (1997). Differential effects of various eicosanoids on the production or prevention of arrhythmias in cultured neonatal rat cardiac myocytes. Prostaglandins, 54, 511-530.
62. LINZ, W., SCHOLKENS, B.A., KAISER, J., JUST, M., QI, B.Y., ALBUS, U., & PETRY, P. (1989). Cardiac arrhythmias are ameliorated by local inhibition of angiotensin formation and bradykinin degradation with the converting-enzyme inhibitor ramipril. Cardiovasc. Drugs Ther., 3, 873-882.
63. 2+ overload with R 56,865 protects against cardiac arrhythmias elicited by ouabain in vivo in guinea-pigs. Eur. J. Pharmacol., 235, 89-93.
64. LU, H.R., REMEYSEN, P. & DE CLERCK, F. (1994). Anti-arrhythmic effects of nebivolol in experimental models in vivo. J. Cardiovasc. Pharmacol., 24, 986-993.
65. LYNCH, J.J., KITZEN, J.M., HOFF, P.T. & LUCCHESI, B.R. (1988). Reduction in digitalis-associated postinfarction mortality with nadolol in conscious dogs. Am. Heart. J., 115, 67-76.
66. MA, G., BRADY, W.J., POLLACK, M. & CHAN, T.C. (2001). Electrocardiographic manifestations: digitalis toxicity. J. Emerg. Med., 20, 145-152.
67. MCGARRY, S.J. & WILLIAMS, A.J. (1993). Digoxin activates sarcoplasmic reticulum Calcium-release channels: a possible role in cardiac inotropy. Br. J. Pharmacol., 108, 1043-1050.
68. MCLAIN, P.L. (1969). Effects of cardiac glycosides on spontaneous efferent activity in vagus and sympathetic nerves of cats. Int. J. Neuropharmacol., 8, 379-387.
69. MCLEMORE, G.L., BILLINGSLEY, M.L. & SEVERS, W.B. (1993). Ouabain cardiotoxicity is enhanced by GABA in anaesthetized rats. Pharmacology, 47, 126-134.
70. MEST, H.J. & BALEWSKA, I. (1988). α- but not β-receptor blocking agents inhibit the antiarrhythmic effect of iloprost on ouabain-induced arrhythmia in guinea-pigs. Biomed. Biochim. Acta, 50, 943-947.
71. 2α, cyclic AMP, and cyclic GMP in canine coronary sinus blood. Prostaglandins Med., 7, 1-13.
72. MEST, H.J., REIN, T. & RIEDEL, A. (1990a). Antagonists of PAF and histamine inhibit ouabain-induced cardiac arrhythmias in sensitized guinea-pigs. Pol. J. Pharmacol. Pharm., 42, 283-289.
73. MEST, H.J., RIEDEL, A. & REIN, T. (1990b). WEB 2086, a novel specific PAF antagonist, prevents PAF induced arrhythmogenicity. Pharmacol. Res., 22, 445-453.
74. 1-imidazoline receptor modulator moxonidine on ouabain-induced cardiac arrhythmia in guinea pigs. Ann. N. Y. Acad. Sci., 763, 620-633.
75. 1 selective blocker, on canine ventricular arrhythmias. Jpn. J. Pharmacol., 43, 179-185.
76. MOFFAT, M.P., FERRIER, G.R. & KARMAZYN, M. (1986). A possible role for endogenous prostaglandins in the electrophysiological effects of acetylstrophanthidin on isolated canine ventricular tissues. Circ. Res., 58, 486-494.
77. MOFFAT, M.P., KARMAZYN, M. & FERRIER, G.R. (1987). Role of prostaglandins in the arrhythmogenic effects of ouabain on isolated guinea pig hearts. Eur. J. Pharmacol., 141, 383-393.
78. MURAMATSU, H., KIYOSUE, T, ARITA, M., ISHIKAWA, T. & HIDAKA, H. (1994). Modification of cardiac sodium current by intracellular application of cAMP. Pflügers Arch., 426, 146-154.
79. 1, but not prostacyclin, on ouabain-induced ventricular fibrillation in guinea-pigs. Fukushima J. Med. Sci., 38, 105-110.
80. NELSON, S.D., LUCCHESI, B.R., SANDERS, D.G. & LYNCH, J.J. (1988). Antiarrhythmic actions of left stellectomy in digitalis-mediated malignant ventricular arrhythmias in the postinfarcted canine heart. J. Cardiovasc. Pharmacol., 12, 196-207.
81. ORDOG, G.J., BENARON, S., BHASIN, V., WASSERBERGER, J. & BALASUBRAMANIUM, S. (1987). Serum digoxin levels and mortality in 5,100 patients. Ann. Emerg. Med., 16, 32-39.
82. PLUNKETT, L.M. & TACKETT, R.L. (1987a). Central dopamine receptors and their role in digoxin-induced cardiotoxicity in the dog. J. Pharm. Pharmacol., 39, 29-34.
83. PLUNKETT, L.M. & TACKETT, R.L. (1987b). Increases in CSF norepinephrine associated with the onset of digoxin-induced arrhythmias. Eur. J. Pharmacol., 136, 119-122.
84. POGATSA, C. (1995). Potassium channels in the cardiovascular system. Diabetes Res. Clin. Pract., 28, 91-98.
85. POGATSA, G., KOLTAI, M.Z., BALKANYI, I., DEVAI, J. & KISS, V. (1985). Effects of various hypoglycaemic sulphonylureas on the cardiotoxicity of glycosides. Eur. J. Clin. Pharmacol., 28, 367-370.
86. POGATSA, C., KOLTAI, M.Z., BALKANYI, I., DEVAI, I., KISS, V. & KOSZEGHY, A. (1988). The effect of various hypoglycaemic sulphonylureas on the cardiotoxicity of glycosides and arrhythmogenic activity due to myocardial ischaemia. Acta Physiol. Hung., 71, 243-250.
87. RABKIN, S.W. (1987). The effect of D-Ala-2-Me-Phe-4-Met-(O)-ol enkephalin on blood pressure, heart rate and digoxin-induced arrhythmias in the guinea pig. Life Sci., 41, 1109-1116.
88. RABKIN, S.W. (1988). The interrelationship of morphine and the parasympathetic nervous system in digoxin-induced arrhythmias in the guinea-pig. Clin. Exp. Pharmacol. Physiol., 15, 565-573.
89. RABKIN, S.W. (1992a). Morphine and the endogenous opioid dynorphin in the brain attenuate digoxin-induced arrhythmias in guinea pigs. Pharmacol. Toxicol., 71, 353-360.
90. RABKIN, S.W. (1992b). Opioid receptor agonists D-Ala-2-Me-Phe-4-Met-(O)- ol enkephalin and ethylketocyclazocine in the brain accentuate digoxin-induced arrhythmias. Can. J. Cardiol., 8, 631-638.
91. RABKIN, S.W. & REDSTON, M. (1989). The effect of inhibitors of endogenous opioid degradation, bacitracin, bestatin, captopril, and D-phenylalanine, on digoxin-induced arrhythmias in guinea pigs. Can. J. Physiol. Pharmacol., 67, 857-863.
92. RABKIN, S.W. & ROOB, O. (1986). Effect of the opiate antagonist naloxone on digitalis-induced cardiac arrhythmias. Eur. J. Pharmacol., 130, 47-55.
93. RABKIN, S.W., EINZIG, S. & BENDITT, D.C. (1987). Morphine suppression of digitalis-induced ventricular arrhythmias. Arch. Int. Pharmacodyn. Ther., 289, 267-277.
94. 2+ in heart cells. J. Biol. Chem., 274, 17820-17827.
95. 2 in cat. Prostaglandins, 33, 339-350.
96. 2α on ouabain-induced cardiac arrhythmias in cats. Life Sci., 41, 2363-2372.
97. 2 on ouabain-induced cardiac arrhythmias in cats: effect of vagotomy and adrenergic neuron blockade. Pharmacol. Res., 22, 151-160.
98. RATNAPALAN, S., GRIFFITHS, K., COSTEI, A.M., BENSON, L. & KOREN, G. (2003). Digoxin-carvedilol interactions in children. J. Pediatr., 142, 572-574.
99. RIEDEL, A. & MEST, H.J. (1987). The effect of PAF (platelet-activating factor) on experimental cardiac arrhythmias and its inhibition by substances influencing arachidonic acid metabolites. Prostaglandins Leukot. Med., 28, 103-109.
100. RIEDEL, A., BRAQUET, P. & MEST, H.J. (1985). The effect of the specific PAF antagonist BN 52021 and the calcium blocker diltiazem on PAF induced arrhythmogenicity. Pharmacol. Res. Commun., 19, 703-712.
101. RIEDEL, A., SCHNEIDER, S. & MEST, H.J. (1988). The effect of substances influencing the arachidonic acid cascade on experimental cardiac arrhythmias. Biomed. Biochim. Acta, 47, 27-30.
102. ROSEN, M.R. & DANILO, P. JR. (1980). Effects of tetrodotoxin, lidocaine, verapamil, and AHR-2666 on ouabain-induced delayed afterdepolarizations in canine Purkinje fibers. Circ. Res., 46, 117-124.
103. RUIZ-CERETTI, E., DELORENZI, F., LAFOND, J.S. & CHARTIER, D. (1988). Insulin and the resting potential of hypoxic substrate-deprived myocardium. Can. J. Physiol. Pharmacol., 66, 202-206.
104. SAGAWA, T., SAGAWA, K., KELLY, J.E., TSUSHIMA, R.G. & WASSERSTROM, J.A. (2002). Activation of cardiac ryanodine receptors by cardiac glycosides. Am. J. Physiol., 282, H1118-H1126.
105. SALINAS, P. & BARRICON, S. (1991). Protective effects of dazmegrel on the PAF potential of ouabain-induced cardiac arrhythmias. Eur. J. Pharmacol., 209, 105-107.
106. SCHLIEPER, P. & TAWFIK, H. (1987). Antiarrhythmic activity of α-tocopherol nicotinate and related compounds and their physico-chemical properties. Arzneimittelforschung, 37, 920-923.
107. SCHWINGER, R.H., BUNDGAARD, H., MULLER-EHMSEN, J. & KJELDSEN, K. (2003). The Na, K-ATPase in the failing human heart. Cardiovasc. Res., 57, 913-920.
108. SIMAAN, J.A. (1993). Influence of pretreatment with phenytoin, lidocaine and quinidine on the cardiodynamic and electrophysiological effects of ouabain in the cat heart-lung preparation. Arch. Int. Pharmacodyn. Ther., 324, 47-59.
109. SZABO C. (1996). DNA strand breakage and activation of poly-ADP ribosyltransferase: a cytotoxic pathway triggered by peroxynitrite. Free Radic. Biol. Med., 21, 855-869.
110. SZABO, C. & DAWSON, V.L. (1998). Role of poly (ADP-ribose) synthetase in inflammation and ischaemia-reperfusion. Trends Pharmacol. Sci., 19, 287-298.
111. 2 induced lasting protection against ouabain arrhythmias in anaesthetized guinea pigs. Biomed. Biochim. Acta, 47, 35-38.
112. TACKETT, R.L. (1986). Enhanced sympathetic activity as a mechanism for cardiac glycoside toxicity in hypomagnesemia. Pharmacology, 32, 141-146.
113. TANZ, R.D., RUSSELL, N.J., BANERIAN, S.P. & SHARP, V.H. (1982). Ouabain-induced tachyarrhythmias and cell damage in isolated perfused guinea-pig hearts: I. Protection by propranolol. J. Mol. Cell Cardiol., 14, 655-671.
114. TEGTMEIER, F., WILHELM, D., ERANKOW, C, THONE, F., VANDEPLASSCHE, L. & PETERS, T. (1992). Effects of R 56865 and phenytoin on mechanical, biochemical, and morphologic changes during ouabain intoxication in isolated perfused rabbit heart. J. Cardiovasc. Pharmacol., 20, 421-428.
115. The Digitalis Investigation Group. (1997). The effect of digoxin on mortality and morbidity in patients with heart failure. N. Engl. J. Med., 336, 525-533.
116. THOMAS, G.P. (1995a). Corynanthine inhibits, while idazoxan potentiates, cardiotoxic effects of ouabain. J. Auton. Pharmacol., 15, 85-91.
117. THOMAS, G.P. (1995b). Studies on the protective effect of azepexole on ouabain-induced cardiac arrhythmias and lethality in guinea-pig. Eur. J. Pharmacol., 276, 215-221.
118. THOMAS, G.P. & STEPHEN, P.M. (1991). Protective action of clonidine against the arrhythmogenic and lethal effects of ouabain in guinea-pigs. Br. J. Pharmacol., 104, 995-999.
119. THOMAS, G.P. & STEPHEN, P.M. (1993). Protective action of methyldopa against ouabain-induced cardiac arrhythmias and lethality. Arch. Int. Pharmacodyn. Ther., 323, 23-31.
120. THOMAS, G.P. & TRIPATHI, K.M. (1986). Effects of α-adrenoceptor agonists and antagonists on ouabain-induced arrhythmias and cardiac arrest in guinea-pig. Br. J. Pharmacol., 89, 385-388.
121. ATP channels. Mol. Cell Biochem., 242, 181-187.
122. TRIPATHI, R.M. & KAUSHAL, R. (1988). Effect of some non-steroidal anti-inflammatory drugs on ouabain-induced arrhythmias in guinea-pigs. Br. J. Pharmacol., 93, 747-750.
123. TRZECIAKOWSKI, J.P. (1994). Protective action of cimetidine against ouabain-induced pressor effects, arrhythmias, and lethality in guinea pigs. J. Cardiovasc. Pharmacol., 7, 622-629.
124. UPRICHARD, A.C., HARRON, D.W., WILSON, R. & SHANKS, R.G. (1988). Effects of the myocardial-selective al-adrenoceptor antagonist UK-52046 and atenolol, alone and in combination, on experimental cardiac arrhythmias in dogs. Br. J. Pharmacol., 95, 1241-1254.
125. VALENTE, R.C., CAPELLA, L.S., MONTEIRO, R.Q., RUMJANEK, V.M., LOPES, A.G. & CAPELLA, M.A. (2003). Mechanisms of ouabain toxicity. FASEB J., 17, 1700-1702.
126. VATNER, S.E., HIGGINS, C.B., FRANKLIN, D. & BRAUNWALD, E. (1971). Effects of a digitalis glycoside on coronary and systemic dynamics in conscious dogs. Circ. Res., 28, 470-479.
127. 4 differs from moricizine and verapamil on ouabain-induced ventricular tachycardia in normomagnesemic conscious dogs. J. Cardiovasc. Pharmacol., 23, 252-258.
128. WARREN, J.L., MCBEAN, A.M., HASS, S.L. & BABISH, J.D. (1994). Hospitalizations with adverse events caused by digitalis therapy among elderly Medicare beneficiaries. Arch. Intern. Med., 154, 1482-1487.
129. 2+ exchange inhibitor, KB-R7943 on ouabain-induced arrhythmias in guinea-pigs. Br. J. Pharmacol., 127, 1846-1850.
130. i in single heart cells revealed by fura-2. Science, 235, 325-328.
131. ATP channel blocker, inhibits ischaemia- and reperfusion-induced ventricular fibrillation in rats. Naunyn-Schmiedeberg's Arch. Pharmacol., 360, 295-300.
132. XIE, Z. (2001). Ouabain interaction with cardiac Na/ K-ATPase reveals that the enzyme can act as a pump and as a signal transducer. Cell Mol. Biol., 47, 383-390.
133. XU, J., HURT, C.M. & PELLEG, A. (1995). Digoxin-induced ventricular arrhythmias in the guinea pig heart in vivo: evidence for a role of endogenous catecholamines in the genesis of delayed afterdepolarizations and triggered activity. Heart Vessels, 10, 119-127.
134. + exchange inhibitor, on ventricular arrhythmias in animal hearts. Eur. J. Pharmacol., 317, 309-316.
135. YAZAR, A., POLAT, G., UN, I., LEVENT, A., KAYGUSUZ, A., BUYUKAFSAR, K. & CAMDEVIREN, H. (2002). Effects of glibenclamide, metformin and insulin on the incidence and latency of death by oubain-induced arrhythmias in mice. Pharmacol. Res. 45, 183-187.
136. ZAKHAROV, S.I., BOGDANOV, K.Y.U. & GOLOVINA, V.A. (1991). Effects of ryanodine on ouabain-induced spontaneous mechanical and electrical oscillations in guinea-pig heart. J. Mol. Cell. Cardiol., 23, 41-46.
137. ZAVECZ, J.H. (1991). The bronchodilator terbutaline enhances digitalis-induced arrhythmia. Am. J. Med. Sci., 302, 148-151.